Long Covid19RESToRENCT06172803
Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
A study testing Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise and Light Stretching/Breathing Exercises in people with Long Covid19 and Exercise Intolerance, run by Columbia University at 1 site in United States.
Trial summary
The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Long Covid19, Exercise Intolerance, Riboflavin-Responsive
- What is being tested?
- Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise and Light Stretching/Breathing Exercises
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 4 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2023to 15 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- English speaking
- Age of 21 years or older
- Diagnosis of long COVID
- Score >0 on energy, daily activities, sleep, chest tightness, or breathlessness on COPD Assessment Test or self-reported brain fog
- Able to use a smartphone.
Who cannot join
- >70years old due to risk of sarcopenia
- Frailty defined as gait speed <1 m/s on 4- Meter Gait Speed (4MGS) test due to falls risk
- Diagnosis of chronic cardiac or pulmonary disease, including atrial fibrillation, ME/CFS, post-concussion syndrome, chronic Lyme disease, lupus, or sarcopenia comorbidities (due to PEM and/or fatigue)
- Medical history of ICU stay for COVID-19 illness due to risk of post-ICU syndrome and increased rehabilitation needs
- Inability to ambulate independently and safely without a walking aide
- Diagnosis of dementia or neurodegenerative disease, multiple sclerosis, or rheumatoid arthritis with associated cognitive dysfunction or fatigue.
Trial locations and contacts
1 site in 1 country.
United States1 site
Columbia University Irving Medical Center
New York, New York, 10032
About this study
Official title: RESToRE: Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Participants will be guided and supported in completing a tailored, 6-week home exercise program to be performed 5 - 6 days a week, prescribed and supervised by rehabilitation therapists. Participants will perform breathing exercises, which will be supervised by an occupational therapist. The focus of Aim 1 is to determine feasibility of implementing RESToRE in long COVID.
Read the detailed description
Long COVID, also known as post-acute coronavirus 2019 syndrome, is characterized by debilitating, multi-organ symptoms beyond 3 months from the onset of acute illness, consistent with autonomic nervous system dysfunction. Prevalence estimate of long COVID is 10 - 20% of survivors of COVID-19, representing about 10-20 million global long-term cases. Multi-organ, autonomic-related symptoms of long COVID, such as exhausting fatigue and post-exertional malaise, are remarkably like post-concussion syndrome and chronic fatigue syndrome. Post-exertional malaise, likely a cardinal symptom of long COVID, is "an exacerbation of some or all of an individual's symptoms after physical or cognitive exertion, or orthostatic stress", significantly impacting functional ability and quality of life. This abnormal response to exertion is often described as "flu-like" and typically includes brain fog. Common "long hauler" symptoms reported in our cohort of patients with long COVID (n=30) were fatigue (>70%), symptoms of dysautonomia (80%, primarily orthostasis), "brain fog" (100%), and new or worse mood symptoms (90%), especially anxiety. Experience from Severe Acute Respiratory Syndrome (SARS-CoV-1) notably showed that survivors suffered chronic fatigue and mental illnesses 4 years after acute viral illness. Rehabilitation studies in coronavirus disease (Covid-19) have targeted sub-acute lung sequelae of Covid-19 rather than post-acute sequalae of long COVID. This study addresses the World Health Organization's urgent call for rehabilitation research for long COVID.
The investigators identified blunted rise in heart rate (HR), called chronotropic intolerance, during maximal cardiopulmonary exercise testing (CPET) in 19 adults with long COVID. Chronotropic intolerance is defined as inability to meet 80% of age-derived heart rate, HR peak. Group HR peak mean (SD) was 69 (7.7) % predicted. This blunted rise in HR is associated with post-exertional malaise, similar to the pattern of symptoms in post-concussion syndrome and chronic fatigue syndrome, which share underlying autonomic nervous system (ANS) dysfunction and impaired cerebral blood flow regulation. The investigators identified a need for more comprehensive and precise measurement of post-exertional malaise in long COVID. In a randomized controlled trial (RCT), the investigators also tested a sub-symptom threshold aerobic exercise program, focused on treating persisting symptoms of post-concussion syndrome. The investigators found this aerobic exercise program reduced persistent symptoms of exercise intolerance, fatigue, and dysautonomia more quickly in subjects compared with a control group of stretching exercises (n=103).
Informed by research in post-concussion syndrome, the investigators are proposing a two-arm randomized controlled trial (RCT) to study the feasibility of an exercise program called, Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise (RESToRE). The central hypothesis is that restoration of autonomic control through RESToRE will resolve persisting symptoms of long COVID faster compared with placebo-like stretching and breathing exercise (without rise in HR). RESToRE is an interdisciplinary, hybrid 8-week intervention consisting of three core components: (1) home-based aerobic exercise, of 20 minutes most days, with HR monitoring at 70-80% of the HR threshold at which symptoms increase, (2) phone-based motivational exercise coaching, 20 minutes weekly; and (3) supervised exercise with an exercise physiologist, twice-monthly in the clinic. Key to RESToRE's feasibility is its telehealth component, including Apple watch and app for HR fidelity monitoring, PhysiTrack's exercise library app, and LifeData dashboard for real-time post-exertional malaise and remote exercise monitoring. Our long-term goal is to establish an efficacious exercise program to speed recovery from long COVID.
- Conditions
- Long Covid19, Exercise Intolerance, Riboflavin-Responsive
- Being tested
- Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise, Light Stretching/Breathing Exercises
- Keywords
- Riboflavin, Rehabiliation, Long COVID
- Medical subject headings
- Post-Acute COVID-19 Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation ExerciseBehavioural
Also called RESToRE
8 week exercise program. 20 minutes of home aerobic exercise most days, phone- based motivational exercise coaching and supervised exercise with our team exercise physiologist.
Light Stretching/Breathing ExercisesBehavioural
The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician (via 20-minute weekly video visits). Exercises performed 5 days a week will not increase HR significantly. Participants will record and track their HR with Apple watch and app; like RESToRE, fidelity of treatment will be objectively measured using HR data.
| Study group | Role | What they receive |
|---|---|---|
| RESToRE | Experimental | Participants will receive RESToRE, an interdisciplinary, hybrid 8- week intervention. Receives: Behavioral: Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise |
| Light Stretching Exercise | Active comparator | The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician. Receives: Behavioral: Light Stretching/Breathing Exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants who enrolled
Feasibility of the RESToRE program will be determined by measuring the number of participants who enroll.
Measured: 10 weeks
Number of participants who completed
Feasibility of the RESToRE program will be determined by measuring the number of participants who complete (participated through the end of the study).
Measured: 10 weeks
Number of participants who adhered to session attendance
Feasibility of the RESToRE program will be determined by measuring the number of participants who achieve ≥80% exercise adherence and session attendance.
Measured: 10 weeks
Secondary outcomes (8)
PROMIS-29 scale score
This toll/questionnaire is designed to measure participants quality of life. Score range is 1-5, with higher score correlating to worse outcomes.
Measured: baseline and post intervention at 8 weeks
Rand 36-Item Health Survey (SF-36) score
This survey evaluates participants mental and physical health with 8 scales aggregated. Score range is 1-6, with the higher score correlating to worse overall health outcomes.
Measured: Baseline and Post Intervention at 8 weeks
VO2 % predicted from Cardiopulmonary Exercise Testing (CPET)
VO2 % predicted (oxygen consumption) based on normative data. Participants' scores will be compared to norms for assessing exercise ability. Group means will be compared.
Measured: Baseline and post intervention at 8 weeks
Number of participants with orthostatic hypocapnia.
The Nasa Lean Test: Participants will stand and lean against a wall with shoulder blades touching and heels 6 - 8 inches from the wall for 10 minutes. HR, BP, SpO2, ETCO2, and symptoms will be recorded in standing leaning posture every minute for 10 mins. Capnography will be used to identify orthostatic hypocapnia.
Measured: baseline and post intervention at 8 weeks
EuroQol: Education Quotient-5D Visual Analogue Scale score
This is to measure quality of life. Score range is 0-100, with 100 being the best health you can imagine and 0 being the worst health.
Measured: baseline and post intervention at 8 weeks
General Symptom Questionnaire (SGQ-30) score
This is to assess participants symptoms regarding pain/fatigue, psychiatric, neurological, and viral-like. Score range is 0 which is not at all to 4 which is very much. Higher score represents worst symptoms.
Measured: baseline and post intervention at 8 weeks
PROMIS Cognitive Function score
This is an 8-item Short Form, measuring perceived difficulties in cognition (e.g., attention, concentration, executive functioning). Score range is 1-5. 1 is very often to 5 which is never. The higher score is better.
Measured: baseline and post intervention at 8 weeks
Global Change Assessment (GCA) score
This is to measure patients change of symptoms in terms of physical function and fatigue throughout the study. Score range is -7 to 7. -7 is a very great deal worse and 7 is a great deal better. The higher the score the better.
Measured: baseline and post intervention at 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2023
- Study start1 Oct 2023
- Primary completion15 Jan 2024
- Study completion15 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Long Covid19Studies of the same condition, open and under way.
- More trials run by Columbia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 4 participants (actual)
Sponsor and investigators
- Lead sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Collaborators
- New York University
- Responsible party
- Sponsor
- Investigators
- Anna Norweg, PhD, Principal investigator, Columbia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06172803
- Sponsor's protocol ID
- AAAU4504 (Aim 1)
- Acronym
- RESToRE
- Status last verified
- Jun 2024
- First submitted
- 14 Dec 2023
- Last updated
- 6 Jun 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- RESToRE: Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
- ClinicalTrials.gov ID
- NCT06172803
- Acronym / sponsor ID
- RESToRE / AAAU4504 (Aim 1)
- Conditions
- Long Covid19, Exercise Intolerance, Riboflavin-Responsive
- Keywords
- Riboflavin, Rehabiliation, Long COVID
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 4 participants (actual)
- Lead sponsor
- Columbia UniversityUniversity, hospital or other
- Collaborators
- New York University
- Study start
- 1 Oct 2023 (actual)
- Primary completion
- 15 Jan 2024 (actual)
- Study completion
- 15 Jan 2024 (actual)
- First posted
- 15 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Participants will be guided and supported in completing a tailored, 6-week home exercise program to be performed 5 - 6 days a week, prescribed and supervised by rehabilitation therapists. Participants will perform breathing exercises, which will be supervised by an occupational therapist. The focus of Aim 1 is to determine feasibility of implementing RESToRE in long COVID.
Detailed description
Long COVID, also known as post-acute coronavirus 2019 syndrome, is characterized by debilitating, multi-organ symptoms beyond 3 months from the onset of acute illness, consistent with autonomic nervous system dysfunction. Prevalence estimate of long COVID is 10 - 20% of survivors of COVID-19, representing about 10-20 million global long-term cases. Multi-organ, autonomic-related symptoms of long COVID, such as exhausting fatigue and post-exertional malaise, are remarkably like post-concussion syndrome and chronic fatigue syndrome. Post-exertional malaise, likely a cardinal symptom of long COVID, is "an exacerbation of some or all of an individual's symptoms after physical or cognitive exertion, or orthostatic stress", significantly impacting functional ability and quality of life. This abnormal response to exertion is often described as "flu-like" and typically includes brain fog. Common "long hauler" symptoms reported in our cohort of patients with long COVID (n=30) were fatigue (>70%), symptoms of dysautonomia (80%, primarily orthostasis), "brain fog" (100%), and new or worse mood symptoms (90%), especially anxiety. Experience from Severe Acute Respiratory Syndrome (SARS-CoV-1) notably showed that survivors suffered chronic fatigue and mental illnesses 4 years after acute viral illness. Rehabilitation studies in coronavirus disease (Covid-19) have targeted sub-acute lung sequelae of Covid-19 rather than post-acute sequalae of long COVID. This study addresses the World Health Organization's urgent call for rehabilitation research for long COVID.
The investigators identified blunted rise in heart rate (HR), called chronotropic intolerance, during maximal cardiopulmonary exercise testing (CPET) in 19 adults with long COVID. Chronotropic intolerance is defined as inability to meet 80% of age-derived heart rate, HR peak. Group HR peak mean (SD) was 69 (7.7) % predicted. This blunted rise in HR is associated with post-exertional malaise, similar to the pattern of symptoms in post-concussion syndrome and chronic fatigue syndrome, which share underlying autonomic nervous system (ANS) dysfunction and impaired cerebral blood flow regulation. The investigators identified a need for more comprehensive and precise measurement of post-exertional malaise in long COVID. In a randomized controlled trial (RCT), the investigators also tested a sub-symptom threshold aerobic exercise program, focused on treating persisting symptoms of post-concussion syndrome. The investigators found this aerobic exercise program reduced persistent symptoms of exercise intolerance, fatigue, and dysautonomia more quickly in subjects compared with a control group of stretching exercises (n=103).
Informed by research in post-concussion syndrome, the investigators are proposing a two-arm randomized controlled trial (RCT) to study the feasibility of an exercise program called, Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise (RESToRE). The central hypothesis is that restoration of autonomic control through RESToRE will resolve persisting symptoms of long COVID faster compared with placebo-like stretching and breathing exercise (without rise in HR). RESToRE is an interdisciplinary, hybrid 8-week intervention consisting of three core components: (1) home-based aerobic exercise, of 20 minutes most days, with HR monitoring at 70-80% of the HR threshold at which symptoms increase, (2) phone-based motivational exercise coaching, 20 minutes weekly; and (3) supervised exercise with an exercise physiologist, twice-monthly in the clinic. Key to RESToRE's feasibility is its telehealth component, including Apple watch and app for HR fidelity monitoring, PhysiTrack's exercise library app, and LifeData dashboard for real-time post-exertional malaise and remote exercise monitoring. Our long-term goal is to establish an efficacious exercise program to speed recovery from long COVID.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| RESToRE | Experimental | Behavioral: Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation ExerciseParticipants will receive RESToRE, an interdisciplinary, hybrid 8- week intervention. |
| Light Stretching Exercise | Active comparator | Behavioral: Light Stretching/Breathing ExercisesThe control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- English speaking
- Age of 21 years or older
- Diagnosis of long COVID
- Score >0 on energy, daily activities, sleep, chest tightness, or breathlessness on COPD Assessment Test or self-reported brain fog
- Able to use a smartphone.
Key exclusion criteria (6 listed)
- >70years old due to risk of sarcopenia
- Frailty defined as gait speed <1 m/s on 4- Meter Gait Speed (4MGS) test due to falls risk
- Diagnosis of chronic cardiac or pulmonary disease, including atrial fibrillation, ME/CFS, post-concussion syndrome, chronic Lyme disease, lupus, or sarcopenia comorbidities (due to PEM and/or fatigue)
- Medical history of ICU stay for COVID-19 illness due to risk of post-ICU syndrome and increased rehabilitation needs
- Inability to ambulate independently and safely without a walking aide
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation ExerciseAlso: RESToRE8 week exercise program. 20 minutes of home aerobic exercise most days, phone- based motivational exercise coaching and supervised exercise with our team exercise physiologist. | Behavioural | RESToRE |
| Light Stretching/Breathing ExercisesThe control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician (via 20-minute weekly video visits). Exercises performed 5 days a week will not increase HR significantly. Participants will record and track their HR with Apple watch and app; like RESToRE, fidelity of treatment will be objectively measured using HR data. | Behavioural | Light Stretching Exercise |
Primary outcome
Number of participants who enrolled
Time frame: 10 weeks
Feasibility of the RESToRE program will be determined by measuring the number of participants who enroll.
Number of participants who completed
Time frame: 10 weeks
Feasibility of the RESToRE program will be determined by measuring the number of participants who complete (participated through the end of the study).
Number of participants who adhered to session attendance
Time frame: 10 weeks
Feasibility of the RESToRE program will be determined by measuring the number of participants who achieve ≥80% exercise adherence and session attendance.
8 secondary outcomes
PROMIS-29 scale score
Time frame: baseline and post intervention at 8 weeks
Rand 36-Item Health Survey (SF-36) score
Time frame: Baseline and Post Intervention at 8 weeks
VO2 % predicted from Cardiopulmonary Exercise Testing (CPET)
Time frame: Baseline and post intervention at 8 weeks
Number of participants with orthostatic hypocapnia.
Time frame: baseline and post intervention at 8 weeks
EuroQol: Education Quotient-5D Visual Analogue Scale score
Time frame: baseline and post intervention at 8 weeks
General Symptom Questionnaire (SGQ-30) score
Time frame: baseline and post intervention at 8 weeks
PROMIS Cognitive Function score
Time frame: baseline and post intervention at 8 weeks
Global Change Assessment (GCA) score
Time frame: baseline and post intervention at 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jun 2024.
Related trials for Long Covid19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Enrolling by invitationPhase 2
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Systemic Inflammation, Neuroinflammation
RecruitingPhase 2
DAOIB for the Treatment of Brain Fog
Long COVID
Active, not recruitingObservational study
Pain in Long COVID-19: The Role of Sleep
Long COVID
Recruiting
Effect of Hi-OxSR for the Treatment of Post COVID Condition
Long COVID, Post COVID-19 Condition
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anna Norweg, PhD principal investigator
Columbia University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise and Light Stretching/Breathing Exercises in people with Long Covid19 and Exercise Intolerance, run by Columbia University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants who enrolled (time frame: 10 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2024.